Bringing a single drug to market can cost $2B+ over 10 years due to lack of enrollment, poor patient retention and data accuracy. Delve Health’s Clinical StudyPal is an end-to-end solution that uses mobile solutions and connected devices to make clinical trials more accessible and inclusive, and improve patient engagement and data compliance.